COMMUNIQUÉS West-GlobeNewswire

TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc.

20/09/2024 - 17:59

TAMPA, FL and COMMACK, NY, Sept. 20, 2024 (GLOBE NEWSWIRE) -- TRxADE Health, Inc. (“TRxADE”) (NASDAQ: MEDS) and Scienture, LLC (“Scienture”), a wholly owned subsidiary of TRxADE, today announced that it is changing its [...]

Onconetix, Inc. Announces 1-for-40 Reverse Stock Split and Results of the Annual Meeting of Stockholders

20/09/2024 - 17:45

CINCINNATI, Ohio, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Onconetix, Inc. (NASDAQ: ONCO) (“Onconetix” or the “Company”), a commercial-stage biotechnology company focused on the research, development, and commercialization of [...]

Psyence Group Enters into Agreement to Dispose of Stake in PsyLabs

20/09/2024 - 17:20

PsyLabs develops and produces certified pharmaceutical-grade natural psychedelics for applications in mental health and well-being NEW YORK, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Psyence Group Inc (" Psyence Group " or the [...]

ChemoMetec makes offer to buy Ovizio Imaging Systems SA

20/09/2024 - 17:06

ANNOUNCEMENT NO. 276 20 September 2024 ChemoMetec makes offer to buy Ovizio Imaging Systems SA ChemoMetec has submitted an indicative offer to buy Belgian company Ovizio Imaging Systems (‘Ovizio’), which has been [...]

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

20/09/2024 - 16:56

Please see enclosed pdf. Attachment 20092024_trading_in_shares_LRA

Range Impact Announces Application to Uplist to the OTCQB Venture Market

20/09/2024 - 15:15

CLEVELAND, OHIO, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) (“Range Impact” or the “Company”), a public company dedicated to improving the health and wellness of people and the planet through a [...]

Koelis Announces Partnership and Initial Experience with DeepHealth for AI-powered Prostate MRI Interpretation and Guidance in Fusion Biopsy

20/09/2024 - 15:07

GRENOBLE, France and PRINCETON, N.J., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Koelis, SAS (“Koelis” or the “Company”, www.koelis.com ), a global leader and innovator in prostate care, announced today the partnership and [...]

Supernus Pharmaceuticals to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit

19/09/2024 - 22:30

ROCKVILLE, Md., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous [...]

ADR Ratio Change

19/09/2024 - 22:30

September 19, 2024 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) ADR Ratio Change Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), an acquisition-focused clinical stage biopharmaceutical company developing a [...]

Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering

19/09/2024 - 22:15

WALTHAM, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization [...]

GENFIT Reports First Half-Year 2024 Financial Results and Provides Corporate Update

19/09/2024 - 22:10

Cash and cash equivalents totaled €61.6 million as of June 30, 2024, excluding the €48.7 million milestone invoiced in June 2024 (received in August 2024) upon first sale of Ipsen’s Iqirvo® (elafibranor) in the U.S. for [...]

GENFIT : Résultats financiers du premier semestre 2024 et point sur les activités de la Société

19/09/2024 - 22:10

Trésorerie et équivalents de trésorerie s’éle vant à 61,6 m illio ns d’euros au 30 juin 2024 n’incluant pas le paiement d’étape de 48,7 millions d’euros facturé en juin 2024 (reçu en août 2024) lors de la première vente [...]

Rezolute Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results and Provides Business Update

19/09/2024 - 22:05

FDA lifts partial clinical holds on ersodetug for the treatment of congenital HI; Phase 3 sunRIZE study to proceed in the U.S. Phase 3 study for ersodetug for the treatment of tumor HI expected to commence in the first [...]

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

19/09/2024 - 22:03

SAN FRANCISCO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative [...]

Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45

19/09/2024 - 22:01

TX45 was well-tolerated with no observed immunogenicity, and demonstrated a favorable PK/PD relationship which was used to identify doses for the Phase 2 clinical trial Results to be presented at the American Heart [...]

Altamira Therapeutics Announces Closing of up to $12.0 Million Public Offering

19/09/2024 - 22:01

Hamilton, Bermuda, Sept. 19, 2024 (GLOBE NEWSWIRE) -- $4 million upfront with up to an additional $8 million of aggregate gross proceeds upon the exercise in full for cash of milestone-linked warrants Altamira [...]

Cytokinetics Announces Upcoming Presentations at the HCMS Scientific Sessions and the HFSA Annual Scientific Meeting

19/09/2024 - 22:00

Analyses of Effects of Aficamten on Key Clinical Outcomes from SEQUOIA-HCM to be Featured in Late Breaking Clinical Trial Presentation at HFSA SOUTH SAN FRANCISCO, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Cytokinetics [...]

Rejuveron Life Sciences AG prend le nom de Centenara Labs AG et fait le point sur les dernières données cliniques

19/09/2024 - 21:47

Les actionnaires approuvent le changement de dénomination sociale sous la marque Centenara Labs AG (« Centenara ») Le changement de marque positionne l’entreprise pour des initiatives stratégiques destinées à soutenir [...]

EON Medical & Wellness: Transforming Healthcare for the Hispanic Community Through Cutting-Edge Telehealth

19/09/2024 - 21:32

Revolutionizing Healthcare Access with Culturally Focused, Language-Accessible Care TAMPA, Fla., Sept. 19, 2024 (GLOBE NEWSWIRE) -- EON Medical + Wellness , a pioneering force in healthcare, is making waves in the [...]